TYMS and colorectal carcinoma: The study showed the probable role of TUG1 as a predictive agent for assessing response to 5‐FU treatment and suggested that TUG1/miR‐197‐5p/TYMS axis might be a useful therapeutic target, especially in 5‐FU‐resistant CRC cell lines.